Some esteemed posters have posited previously, that by the time two or three indications of NZ 2591 have passed phase III trials, received FDA approval and licensed (perhaps in a similar style deal with Trofenitide and Acadia) that it might take as long as year 2027/28.
I see so much investment and work to get us to that point where NEU will reap full value from their assets, royalties from all four indications - can you imagine?
Maybe when we reach that point, and NEU hasnt been sold off, we will see those dividends flowing.
Some esteemed posters have posited previously, that by the time...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.66 |
Change
0.005(0.04%) |
Mkt cap ! $1.746B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.086M | 226.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 707 | $13.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 374 | 2 |
View Market Depth
| Last trade - 15.47pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |